MAX BioPharma

MAX BioPharma Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • (In Progress)
  • Investors
  • 2

MAX BioPharma General Information


Developer of novel small molecule lipids intended to provide treatments for fatal and debilitating disorders. The company develops oxysterols which has the ability to stimulate bone growth and block cancer cell growth as well as inhibit their ability to metastasize, enabling doctors to treat pancreatic cancer, breast cancer and hematologic malignancies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Primary Office
  • 2870 Colorado Avenue
  • Santa Monica, CA 90404
  • United States
+1 (310) 000-0000

MAX BioPharma Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MAX BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 03-Mar-2020 00000 In Progress Pre-Clinical Trials
4. Angel (individual) 13-Sep-2018 00.000 00000 Completed Pre-Clinical Trials
3. Grant 24-May-2018 00.000 00000 Completed Pre-Clinical Trials
2. Grant 01-Jan-2016 $2.19M $250K Completed Startup
1. Seed Round $250K $250K Completed Startup

MAX BioPharma Executive Team (4)

Name Title Board Seat Contact Info
Farhad Parhami Ph.D Co-Founder, President & Chief Executive Officer
Gonzalo Payan Director of Finance and Operations
Michael Jung Ph.D Scientific Co-Founder
William Matsui MD Scientific Co-Founder

MAX BioPharma Investors (2)

To view MAX BioPharma‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Institute for Regenerative Medicine Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Ready to get started?

Request a free trial